Tumor-infiltrating lymphocyte-derived MLL2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma.
Nisha ZhuLiang DingYong FuYan YangSheng ChenWantao ChenMengxiang ZhaoXingxing ZhaoZhanyi LuYan-Hong NiQingang HuPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2019)
TIL-derived MLL2 in invasive tumor front was an independent prognostic factor of DFS for early-stage OSCC patients.